Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

8.3%

2 terminated out of 24 trials

Success Rate

88.2%

+1.7% vs benchmark

Late-Stage Pipeline

38%

9 trials in Phase 3/4

Results Transparency

20%

3 of 15 completed with results

Key Signals

3 with results88% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (3)
P 2 (6)
P 3 (6)
P 4 (3)

Trial Status

Completed15
Withdrawn3
Unknown2
Terminated2
Recruiting2

Trial Success Rate

88.2%

Benchmark: 86.5%

Based on 15 completed trials

Clinical Trials (24)

Showing 20 of 20 trials
NCT06422078RecruitingPrimary

A Non-interventional, Prospective Study With Benralizumab

NCT06299306TerminatedPrimary

REACT - REAl Care for AsThma - A Disease Study to Identify Patients With Severe Uncontrolled Asthma

NCT00489346Phase 3CompletedPrimary

A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)

NCT00092885Phase 3Completed

An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)

NCT00092105Phase 3CompletedPrimary

Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)

NCT00092092Phase 4CompletedPrimary

Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254)

NCT05270278Completed

Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy

NCT05937334RecruitingPrimary

The Cohort Study for Asthma in China

NCT00540839Phase 3WithdrawnPrimary

A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)

NCT02227394Phase 2Completed

Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients

NCT03989635Phase 2Withdrawn

Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma.

NCT03839433Phase 4CompletedPrimary

The Mannitol-Asthma-Ciclesonide-Study

NCT03034447Not ApplicableCompletedPrimary

Sleep Apnea in Asthmatic Children and Teenagers

NCT00830427Phase 2WithdrawnPrimary

A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects

NCT00734318Phase 3CompletedPrimary

Study of FlutiForm® Versus Fluticasone Plus Formoterol in Adult Subjects With Severe Asthma

NCT02805907Phase 4CompletedPrimary

Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD)

NCT00213252Phase 2CompletedPrimary

Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma

NCT00825903Not ApplicableCompletedPrimary

The Effects of Exercise on Physiological and Psychological Parameters in an Asthmatic Population

NCT00640120CompletedPrimary

Wheeze Detection in Children During Dynamic Bronchial Situations Measured by WIM-PC™ Recording

NCT00385593Phase 3TerminatedPrimary

Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults

Scroll to load more

Research Network

Activity Timeline